The shortest path from a proven molecule to a partner
A scientist with a strong track record and a de-risked, clinically tested molecule should be able to sit across from the people who can actually develop it. Too often the road there runs through layer after layer, and by the time the inventor reaches the table, ownership has been diluted, obligations have piled up, and the science has waited.
There are capable professionals at every step, and there are moments a company genuinely needs them. But for an inventor whose asset is already real, the distance to a serious partner can be far shorter than the traditional route suggests.
That is the work we do. We represent scientists, and only scientists. We take a proven program, de-risk and organize it, establishing safety, defining the patient population, cleaning the intellectual property, and organizing the evidence a buyer will test, and we bring it directly to large pharma, with the inventor's ownership and leverage intact. The value is created before the deal, in how ready the program is and how directly it reaches the right desk.
Breakthroughs should not have to wait in line. If you are a scientist whose molecule has earned its data, there is a way to the table that keeps it yours.
Have a program worth de-risking?
See how we work with inventors →Filling a pipeline gap?
Talk to us →